TPD52L2 and nonpapillary renal cell carcinoma: To explore whether TPD52L2 is a potential oncogene in ccRCC, the expression level of TPD52L2 was analyzed in relation to the clinical characteristics of ccRCC patients based on sequencing data from TCGA.